EducationTranslational Lecture Series

Skin Immune Response: Friend or Foe?

JDD Multimedia

Translational Lecture Series

Dr. Jenny Kim will review skin’s important role as an immune organ and what happens when dysregulation occurs.

Learn More

Skin Immune Response: Friend or Foe? - Exploring the Role of Inflammation and Microbes in Acne Pathogenesis

featuring Dr. Jenny Kim

In this edition of the GW Translational Lecture Series, Dr. Jenny Kim reviews the skin’s important role as an immune organ and what happens when dysregulation occurs.

Presenter

  • Jenny Kim, MD, PhD is a Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA and Chief of Dermatology at the Greater Los Angeles Healthcare System Veterans Affairs.

You May Also Like

Journal of Drugs in Dermatology JDD featuring Dr. Jacob Beer in JDD Re:View, a discussion of JDD articles and specific topics. This article highlights Aesthetics Is Changing. Here’s What We’re Seeing?

JDD Re:View With Dr. Beer

| Aesthetics, Featured Articles, JDD Re:View, Latest News | No Comments
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Journal of Drugs in Dermatology JDD Article about Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome

| Featured Articles, Latest News, Skin of Color | No Comments
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Journal of Drugs in Dermatology JDD Article about Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab. Image shows thumb and nail or patient.

Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab

| Case Reports, Featured Articles, Latest News | No Comments
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…

Leave a Reply